Related references
Note: Only part of the references are listed.Dengue Virus Type 3 Infection in Traveler Returning from West Africa
Laetitia Ninove et al.
EMERGING INFECTIOUS DISEASES (2009)
Reconstructing historical changes in the force of infection of dengue fever in Singapore: implications for surveillance and control
Joseph R. Egger et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
Vaccines against dengue: a review of current candidate vaccines at advanced development stages
Joachim Hombach
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH (2007)
Denque prevention and 35 years of vector control in Singapore
Eng-Eong Ooi et al.
EMERGING INFECTIOUS DISEASES (2006)
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax™-DEN2) vaccine:: Phase I clinical trial for safety and immunogenicity
Farshad Guirakhoo et al.
HUMAN VACCINES (2006)
Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: Infant mice provide an accurate surrogate for the test in monkeys
TP Monath et al.
BIOLOGICALS (2005)
Share Paper
